- The FDA approved Epidiolex, a drug made to treat two kinds of epilepsy
- This is the first prescription drug approval for a drug made from natural marijuana
- A reschedule for CBD is expected to come in the near future by the DEA
Another strong step towards common sense legalization was taken today, as the FDA announced their approval of a drug made from naturally derived CBD. The drug’s official name is Epidiolex and it is produced by GW Pharmaceuticals, a company located in the United Kingdom. This CBD based drug is made to treat two types of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.
The FDA Commissioner, Dr. Scott Gottlieb, released a statement saying, “Sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies.” He would go on to say, “We’ll continue to support rigorous scientific research on the potential medical uses of marijuana derived products.”
The work of cannabis community advocates is being heard. The FDA’s stated scientific research support is a crucial step and it shows that we are slowly moving in the right direction.
Although FDA approval is massively important, prescriptions can’t be written for patients until CBD is rescheduled by the DEA. The FDA is expected to recommend a reschedule soon, so patients can begin to receive the treatment they need.
Today is a good day for the Cannabis Community, as those suffering from the previously stated conditions will have full access to their medication, as it should be.
Make sure to follow #BricksBlog for all Cannabis News!!